Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05442216 |
| Title | Tagraxofusp and Azaxitadine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents (TAGALONG) |
| Acronym | TAGALONG |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Joshua Zeidner |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Miami | RECRUITING | Miami | Florida | 33136 | United States | Details |
| AdventHealth Orlando | RECRUITING | Orlando | Florida | 32803 | United States | Details |
| Roswell Park Cancer Institute | RECRUITING | Buffalo | New York | 14263 | United States | Details |
| University of North Carolina at Chapel Hill | RECRUITING | Chapel Hill | North Carolina | 27599 | United States | Details |
| Atrium Health Wake Forest Baptist Comprehensive Cancer Center | RECRUITING | Winston-Salem | North Carolina | 27157 | United States | Details |
| Penn Medicine Abramson Cancer Center | RECRUITING | Philadelphia | Pennsylvania | 19104 | United States | Details |
| Lifespan Health System Rhode Island Hospital | RECRUITING | Providence | Rhode Island | 46278 | United States | Details |